Tamer I. Khayal, Chief Commercial Officer at TransMedics Group, Inc. (TMDX), sold 11,678 shares at $130.07 ($1.5M) on 2024-05-06, disclosed to the SEC on 2024-05-08.
Scheduled sale ($1.5M) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $130.07 | 5,839 | $759K | 50.0% |
| 2 | $130.07 | 5,839 | $759K | 50.0% |
| Total | $130.07 avg | 11,678 | $1.5M | 100% |
| Filing → |
| TMDX | SELL | 2024-12-04 | $187K | — | Filing → |
| TMDX | SELL | 2024-11-13 | $263K | — | Filing → |
| TMDX | SELL | 2024-11-05 | $179K | — | Filing → |